Testing effectiveness (Phase 2)Study completedNCT00074308
What this trial is testing
Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
Who this might be right for
Recurrent MelanomaStage III MelanomaStage IV Melanoma+1 more
National Cancer Institute (NCI) 40